A randomized patient-and-physician blinded, placebo-controlled, 24-week study to assessthe safety, tolerability and efficacy of LMB763 in patients with diabetic nephropathy

Project: Research project

Project Details

Description

A randomized patient-and-physician blinded, placebo-controlled, 24-week study to assess the safety, tolerability and efficacy of LMB763 in patients with diabetic nephropathy
StatusActive
Effective start/end date8/1/188/31/21

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.